ATYR

aTyr Pharma
ATYR

Overview Fund Activity

43 hedge funds and large institutions have $33.9M invested in aTyr Pharma in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 11 closing their positions.

Holders
43
Holders Change
-6
Holders Change %
-12.24%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
5
Increased
17
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$1.78M
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$3.31M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$442K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$354K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$220K

Top Sellers

1
RCM
1
Riverhead Capital Management
Delaware
$253K
2
TAM
2
Tiverton Asset Management
Delaware
$680K
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$0
4
ARTA
4
A.R.T. Advisors
New York
$0
5
GCP
5
GSA Capital Partners
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CS
51
Credit Suisse
Switzerland
– -$33K -857 Closed
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
– -$15K -393 Closed
DADC
53
D.A. Davidson & Co
Montana
– -$5K -143 Closed
1 2
3